BioSpace News Archive

The single-arm, observational study is designed to evaluate the safety and effectiveness of the Durablate catheter to treat ventricular tachycardia

Endocanna Health Creates New Paradigm of Personalized Medicine Connecting Human DNA with Cannabis Genetic Profiles

Mobile health screening leader reaches milestone Mobile health screening leader reaches milestone

The Foundation for the National Institutes of Health (FNIH) has selected three finalists of the inaugural Trailblazer Prize for Clinician-Scientists (Trailblazer Prize)

Crucial findings for women struggling to get pregnant to be discussed at 70th AACC Annual Scientific Meeting

Women’s brains are much more vulnerable than men’s to injury from repeated soccer heading, according to a new study by researchers at Albert Einstein College of Medicine, part of Montefiore.

July 31, 2018 15:00 UTC With Prescription Drug Plans, Mutual of Omaha Offers Full Suite of Senior Health Solutions from Single Trusted Source OMAHA, Neb.--( BUSINESS WIRE )-- A leader in senior health solutions, Mutual of Omaha will offer Medicare Part D prescription drug plans to seniors across the country, the company announced. Pending regulatory approval, Medicare Part D plans will be available in

Cerenis Therapeutics (FR0012616852 – CEREN – PEA PME eligible), an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular, metabolic diseases, and new HDL-based vectors for the targeted drug delivery in the oncology field announces today the appointment of Barbara Yanni to its Board of Directors as an Independent Director.

THE EMERGING TRACKING SOLUTION IN HEALTHCARE

A research abstract authored by pathologists at Inform Diagnostics has been awarded “Outstanding Abstract” in the 2018 Therapeutic Drug Management and Toxicology Division Abstract Competition conducted by the American Association for Clinical Chemistry (AACC).